AHC
LLY icon

Adell Harriman & Carpenter’s Eli Lilly LLY Stock Holding History

Adell Harriman & Carpenter’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.8M Buy
14,015
+1,014
+8% +$1.04M 0.86% 37
2026
Q1 		$12M Buy
13,001
+146
+1% +$148K 0.73% 39
2025
Q4 		$13.8M Buy
12,855
+559
+5% +$535K 0.82% 35
2025
Q3 		$9.38M Sell
12,296
-2,726
-18% -$2.03M 0.57% 40
2025
Q2 		$11.7M Buy
15,022
+686
+5% +$533K 0.78% 33
2025
Q1 		$11.8M Buy
14,336
+1,669
+13% +$1.39M 0.89% 31
2024
Q4 		$9.78M Buy
12,667
+1,008
+9% +$835K 0.68% 37
2024
Q3 		$10.3M Buy
11,659
+1,910
+20% +$1.72M 0.75% 36
2024
Q2 		$8.83M Buy
9,749
+2,613
+37% +$2.09M 0.68% 38
2024
Q1 		$5.55M Buy
7,136
+1,580
+28% +$1.12M 0.46% 56
2023
Q4 		$3.24M Buy
5,556
+2,574
+86% +$1.5M 0.3% 72
2023
Q3 		$1.6M Buy
2,982
+832
+39% +$429K 0.17% 87
2023
Q2 		$992K Buy
2,150
+1,443
+204% +$605K 0.1% 100
2023
Q1 		$243K Sell
707
-150
-18% -$50.6K 0.03% 159
2022
Q4 		$314K Sell
857
-200
-19% -$70.9K 0.04% 147
2022
Q3 		$342K Buy
1,057
+200
+23% +$63.4K 0.04% 140
2022
Q2 		$278K Sell
857
-26
-3% -$7.8K 0.03% 127
2022
Q1 		$253K Sell
883
-1,210
-58% -$311K 0.02% 159
2021
Q4 		$578K Sell
2,093
-5,463
-72% -$1.38M 0.05% 125
2021
Q3 		$1.75M Buy
+7,556
New +$1.86M 0.18% 97
2016
Q2 		– Sell
-2,826
Closed -$204K – 137
2016
Q1 		$204K Buy
2,826
+376
+15% +$28.4K 0.05% 131
2015
Q4 		$206K Hold
2,450
– – 0.06% 130
2015
Q3 		$205K Buy
2,450
+50
+2% +$4.22K 0.06% 135
2015
Q2 		$200K Buy
+2,400
New +$183K 0.05% 141

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adell Harriman & Carpenter's LLY Position: Q2 2026 in Review

Adell Harriman & Carpenter increased its Eli Lilly (LLY) stake by 7.8% in Q2 2026, buying an estimated $1.04M and bringing the position to 14,015 shares worth $16.8M. The position accounts for 0.86% of the portfolio, ranked #37.

Adell Harriman & Carpenter first reported a position in LLY in Q2 2015 and has held it in 24 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Adell Harriman & Carpenter held 14,015 shares of Eli Lilly worth $16.8M as of Q2 2026.
  • Adell Harriman & Carpenter bought 1,014 Eli Lilly shares in Q2 2026, an estimated $1.04M.
  • Eli Lilly made up 0.86% of Adell Harriman & Carpenter's portfolio in Q2 2026, its #37 holding.
  • Adell Harriman & Carpenter first reported a position in Eli Lilly in Q2 2015 and has held it in 24 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Adell Harriman & Carpenter's 13F filing for Q2 2026, filed 4 Aug 2026.